Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.900
+0.170 (4.56%)
Nov 5, 2025, 4:00 PM EST - Market closed

Alterity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Nov '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
716014112244
Upgrade
Market Cap Growth
542.62%327.48%23.14%-47.27%-50.72%259.32%
Upgrade
Enterprise Value
44576-5-417
Upgrade
Last Close Price
3.734.091.812.796.1113.00
Upgrade
PS Ratio
19.8216.785.224.366.1113.45
Upgrade
PB Ratio
2.542.151.520.750.881.92
Upgrade
P/TBV Ratio
2.542.151.520.750.881.92
Upgrade
EV/Sales Ratio
12.4415.972.22--5.37
Upgrade
Debt / Equity Ratio
0.000.000.010.010.000.00
Upgrade
Asset Turnover
0.170.170.170.110.140.20
Upgrade
Quick Ratio
12.6212.623.105.586.7910.56
Upgrade
Current Ratio
12.9812.983.546.177.0710.92
Upgrade
Return on Equity (ROE)
-43.23%-43.23%-104.47%-47.38%-38.97%-81.39%
Upgrade
Return on Assets (ROA)
-28.09%-28.09%-52.66%-26.64%-25.85%-43.62%
Upgrade
Return on Capital (ROIC)
-32.43%-32.43%-66.27%-31.21%-29.30%-50.30%
Upgrade
Earnings Yield
-11.27%-13.31%-91.15%-80.84%-41.06%-26.24%
Upgrade
FCF Yield
-10.50%-12.55%-60.11%-117.35%-39.72%-29.72%
Upgrade
Buyback Yield / Dilution
-75.31%-75.31%-50.29%-0.91%-41.79%-89.62%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q